Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Mesoblast Limited (MESO) Consolidated Net Income/Loss data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Consolidated Net Income/Loss |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$202.48M |
|
$1.79M |
|
$579.82M |
|
$782.31M |
|
$128.07M |
|
$60.13M |
|
$79.55M |
|
$207.62M |
|
$574.68M |
|
$5.88M |
|
$574.68M |
|
128.85M |
|
| Cash Flow Statement Financials | |
$-30.34M |
|
$-0.61M |
|
$-1.13M |
|
$161.55M |
|
$129.97M |
|
$-31.58M |
|
$9.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|